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Abstract Treatment of Chinese hamster ovary K1 cells with
phosphatidylserine (PS) caused typical apoptosis with distinct
morphological and biochemical features in a dose- and time-
dependent manner. However, unlike camptothecin-induced apo-
ptosis, changes in mitochondrial transmembrane potential were
not observed. In addition, cytochrome c release did not occur in
PS-induced apoptosis. A pan caspase inhibitor, Z-VAD,
significantly inhibited the apoptosis, but inhibitors of caspase-1,
-3, -8 and -9 did not. Activities of caspase-1, -3, -8 and -9 were
increased by treatment of the cells with camptothecin, but not
with PS. These results suggest that PS-induced apoptosis occurs
without the collapse of mitochondrial transmembrane potential
and without the release of cytochrome c, in a manner independent
of caspase-1, -3, -8 and -9. ß 2001 Federation of European
Biochemical Societies. Published by Elsevier Science B.V. All
rights reserved.
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1. Introduction
Phosphatidylserine (PS), a negatively charged phospholipid,
is a major component of the mammalian cell membrane,
which is normally con¢ned to the cytoplasmic lea£et of the
plasma membrane lipid bilayer, but apparently relocates to
the extracellular lea£et in apoptotic cells [1]. PS on the extra-
cellular lea£et allows phagocytes to recognize and engulf apo-
ptotic cells [2]. Uchida et al. recently reported that excess PS
induced an apoptotic process highly speci¢c for PS in Chinese
hamster ovary K1 (CHO-K1) cells [3]. PS exogenously added
to the cells was intracellularly incorporated by an enzyme,
aminophospholipid translocase [4]. A mutant CHO cell line
defective in this enzyme showed no endocytic uptake of PS [5].
However, the molecular mechanism of the PS-induced apo-
ptosis remains ill-de¢ned.
Apoptosis is a form of cell death, which occurs physiolog-
ically as well as pathologically [6]. Characteristic changes, in-
cluding cell shrinkage, plasma membrane blebbing, chromatin
condensation, DNA fragmentation and formation of apopto-
tic bodies, are known to be associated with apoptosis [7]. PS
externalization [2,8] and various mitochondria changes, such
as the loss of inner transmembrane potential (v8) [9], occur in
a variety of types of apoptosis.
Sequential activation of cysteine proteinases, now known as
the caspase cascade, plays a pivotal role in the execution
phase of apoptosis [10^13]. There are several such caspase
cascades depending on the cell type and apoptotic stimuli.
The proteolytic cascade is initiated by a variety of stimuli,
including changes in mitochondria, and ligation of the tumor
necrosis factor receptor [14] and CD95 (Fas/APO-1) receptor
[15]. Caspases catalyze the proteolytic cleavage at a speci¢c
peptide bond, Asp in the P1 site. Hence, based on their spe-
ci¢c cleavage sites, an increasing number of synthetic sub-
strates and inhibitors for all caspases have been designed,
and are now extensively used in apoptosis research [16].
In the present study, we con¢rmed that, using CHO-K1
cells, PS caused typical apoptosis with distinct morphological
and biochemical features in a dose- and time-dependent man-
ner. PS, however, did not induce apoptosis in a mutant CHO
cell line defective in aminophospholipid translocase. Using
inhibitors and substrates speci¢c for various caspases, we
found novel characteristics of the PS-induced apoptosis in
CHO-K1 cells.
2. Materials and methods
2.1. Materials
PS from bovine brain, type III, (80%) was purchased from Sigma,
USA. A pan caspase inhibitor Z-VAD-CH2-DCB was purchased
from Phoenix Pharmaceutical, USA. An inhibitor for caspase-3, III
Ac-DEVD-CMK was from Calbiochem, USA. Inhibitors, Ac-YVAD-
CMK, Ac-IETD-CHO, Ac-LEHD-CHO and £uorogenic substrates
for caspases, Ac-DEVD-MCA (4-methyl-coumaryl-7-amide), Ac-
YVAD-MCA, Ac-IETD-MCA and Ac-LEHD-MCA were from Pep-
tide Institute Inc., Japan. 7-Amino-4-methylcoumarin (AMC) as a
calibration standard was obtained from Biomedicals Inc., USA.
2.2. Cell culture
CHO-K1 ¢broblasts (ICRB 9018; Health Science Research Resour-
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ces Bank) were maintained as a monolayer culture in Ham’s F12
medium (Nissui Pharmaceutical Co., Ltd., Japan), supplemented
with 2 mM L-glutamine, 10% heat-inactivated fetal bovine serum,
penicillin G (100 U/ml), and streptomycin sulfate (100 Wg/ml). A mu-
tant cell line with reduced levels of aminophospholipid translocase,
UPS-1, was a kind gift from Dr. K. Hanada (National Institute of
Infectious Disease, Japan). Cells were incubated in a humidi¢ed at-
mosphere with 5% CO2 at 37‡C.
2.3. Preparation of PS vesicles and their induction of apoptosis
PS in a chloroform:methanol (9:1) solution (10 mg/ml) was evapo-
rated in a glass tube and resuspended in serum-free Ham’s F12 me-
dium, then vortexed. The suspension was sonicated with a probe-type
sonicater three times for 5 min to make PS vesicles immediately before
use.
Cells (5U105) seeded in a 35 mm tissue culture dishes in 2 ml of
medium were cultured for 24 h, subsequently the medium was
changed to fresh medium containing various concentrations of PS
vesicles, and the mixture was incubated at 37‡C for the speci¢ed
period.
2.4. Measurement of characteristic changes of apoptosis
Cell viability was measured by £ow cytometry (FCM) (EPICS XL
Coulter Co., USA) according to the procedure of Darzynkiewicz et al.
after staining with £uorescein diacetate (Wako, Japan) [17].
Apoptotic cells were determined on the basis of characteristic
changes in nuclear morphology after staining with Hoechst 33342
(Sigma, USA) as previously described [18]. Percentage of apoptotic
cells with DNA fragmentation was measured as sub-G1 peak detect-
ing propidium iodide (PI)-stained cells using FCM after extraction
with 70% ethanol [19].
v8 was assayed by FCM after staining the cells with rhodamine
123 (Sigma, USA) essentially according to the method of Shimizu et
al. [20]. Simultaneously, cell death with loss of structural integrity of
the plasma membrane was detected by staining with PI.
Western blotting to detect cytochrome c in the cytosol was con-
ducted essentially according to the method of Kitagawa et al. [21].
Brie£y, the collected cultured cells (2U107) were resuspended in 0.4
ml of extraction bu¡er (0.25 M sucrose, 10 mM Tris^HCl, pH 7.8, 5
mM MgCl2, 1 mM dithiothreitol (DTT), 0.5 mM phenylmethylsul-
fonyl £uoride) and homogenized with a Te£on homogenizer. After
removal of mitochondria by centrifugation (12 000 rpm, 30 min, at
4‡C), Western blotting analysis of cytochrome c in the cell extract was
conducted. Immune complexes were visualized with an ECL kit
(Amersham Pharmacia Biotech., USA), using a primary mouse mono-
clonal antibody against cytochrome c (Santa Cruz Biotechnology,
USA).
Caspase activity was assayed using caspase £uorogenic substrates
according to the method described previously with slight modi¢ca-
tions [22]. After incubation, collected cells were lysed with lysis bu¡er
(10 mM Tris^HCl, pH 7.5, 130 mM NaCl, 1% w/v Triton X-100, 10
mM Na2HPO4, 10 mM Na4P2O7). Lysates were vortexed and centri-
fuged (15 000 rpmU10 min) at 4‡C. The protein concentration of the
supernatant was determined using a Bio-Rad protein assay kit (Bio-
Rad, Richmond, USA). Protein concentrations were then adjusted to
50 Wg/ml with reaction bu¡er (20 mM HEPES, pH 7.5, 10% w/v
glycerol, 2 mM DTT). Aliquots of 1 ml were incubated at 37‡C for
1 h with 5 Wl of caspase £uorogenic substrates (50 mM in dimethyl
sulfoxide).
3. Results
3.1. PS-induced apoptosis in CHO-K1 cells
The viability of CHO-K1 cells decreased with increasing
concentration of PS (Fig. 1A) as well as with incubation
time with PS (Fig. 1B). However, the mutant cell line with
lower aminophospholipid translocase activity, UPS-1 cells
[23], did not show a decrease in viability (Fig. 1A). These
results suggested that the invasion of PS into the cytoplasmic
side of the cell membrane by aminophospholipid translocase
is an essential step in cell death induced by PS.
PS-treated cells showed the typical morphology character-
istic of apoptosis, such as cell shrinkage and plasma mem-
brane blebbing as well as changes in nuclear morphology,
such as chromatin condensation and segregation (data not
shown). DNA fragmentation (the so-called ladder pattern)
on agarose gel electrophoresis was observed after PS treat-
ment (data not shown). The observation of cells containing
the sub-G1 DNA fraction suggested that the treatment with
PS could induce extensive DNA fragmentation in a dose-de-
pendent manner (data not shown). These results strongly sug-
gested that PS induced typical apoptosis in CHO-K1 cells.
3.2. PS-induced apoptosis does not accompany the loss of v8
and cytochrome c release into the cytosol
To further characterize the PS-induced apoptosis, we exam-
ined the decrease in mitochondrial membrane potential, which
has been reported to occur in association with apoptosis in a
variety of cells. Most of the non-treated living cells were PI-
negative with high v8 (PI3v8high) (Fig. 2A). The PS-treated
cells did not show a decrease in v8 regardless of the PS
concentration used (Fig. 2C,D).
Fig. 1. E¡ects of exogenous PS on viability of CHO-K1 and UPS-1
cells. CHO-K1 or UPS-1 cells (5U105) seeded in 35 mm dishes in
2 ml of medium were incubated for 24 h with PS at the concentra-
tions shown on the abscissa, and then viable cells were scored as de-
scribed in the text. A: Dose-dependent decrease in cell viability.
Bars represent mean þ S.E.M. (n = 3). b : CHO; F : UPS-1. B: Time-
dependent decrease in CHO-K1 cell viability. CHO-K1 cells
(5U105) seeded cells in 35 mm dishes in 2 ml of medium were cul-
tured with PS. After incubation for the times shown on the abscissa,
viable cells were scored as described in the text. Bars represent
mean þ S.E.M. (n = 3). b : 0 mM PS; F : 1 mM PS; R : 3 mM PS.
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Moreover, to exclude the possibility that apoptosis without
the loss of mitochondrial membrane potential was due to cell
line-speci¢c characteristics, we examined the changes in v8
after treatment with camptothecin, an inhibitor of topoiso-
merase I, which can induce typical apoptosis [24] (Fig. 2B).
After treatment with camptothecin (40 Wg/ml for 24 h), the
cells showed a marked decrease in v8 and an increase in PI
staining. Consequently, the percentage of a new fraction of
cells showing low v8 and high PI staining increased mark-
edly, from 0.02% in controls to 43%, unlike the results ob-
tained with PS treatment. Hence, these results clearly showed
that PS induces apoptosis speci¢cally without the loss of v8
in CHO-K1 cells.
The activation of caspase-9 requires cytochrome c release
from mitochondria [25]. Fig. 3 shows cytochrome c release
into the cytosol in response to PS- or camptothecin-induced
apoptosis. The release of cytochrome c into the cytosol was
induced by camptothecin, but not by PS treatment. These
results strongly suggested that PS-induced apoptosis could
occur independently of the mitochondrial alterations.
3.3. Inhibition of apoptotic phenotypes by a pan caspase
inhibitor, but not by caspase-1, -3, -8 and -9 inhibitors
To assess the involvement of caspase(s) in this apoptotic cell
death, we examined the e¡ects of several caspase inhibitors,
Z-VAD-CH2DCB (pan caspase inhibitor), Ac-DEVD-CMK
(caspase-3/7 inhibitor), Ac-YVAD-CMK (caspase-1/4 inhibi-
tor), Ac-IETD-CHO (caspase-8/6, granzyme B inhibitor) and
Ac-LEHD-CHO (caspase-9 inhibitor) on the appearance of
apoptotic cells and sub-G1 fraction. Both changes were sig-
ni¢cantly inhibited by a pan caspase inhibitor, Z-VAD-
CH2DCB, but not by several caspase inhibitors, such as Ac-
DEVD-CMK, Ac-YVAD-CMK, Ac-IETD-CHO and Ac-
LEHD-CHO. These results suggested that caspases-1, -3, -8
Fig. 2. Changes in v8 after PS or camptothecin treatment of CHO-K1 cells. Cells were double-stained with rhodamine 123 and PI after treat-
ment with PS at the concentrations shown in the lower part of the two lower panels, and with camptothecin (10 Wg/ml) for 24 h. Flow cyto-
metric analysis was performed as described in the text. PI £uorescence intensity (indicating loss of plasma membrane integrity) was plotted
against rhodamine 123 £uorescence intensity (indicating v8).
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and -9 are not involved in PS-induced apoptosis in CHO-K1
cells, although caspase(s) other than these must be involved in
PS-induced apoptosis.
3.4. Caspase-1, -3, -8 and -9 activities were not observed in
PS-induced apoptosis
To con¢rm the above ¢ndings, we measured the activation
of these caspases in the PS-induced apoptosis. Cytosolic ex-
tracts from CHO-K1 cells were subjected to protease activity
assay using speci¢c £uorogenic substrates: Ac-DEVD-MCA
(caspase-3/7), Ac-YVAD-MCA (caspase-1/4), Ac-IETD-MCA
(caspase-8/6, granzyme B) and Ac-LEHD-MCA (caspase-9)
(Fig. 5). No increases were observed in the activity of any
of the caspases tested in the PS-treated cells. In contrast,
marked increases in these activities, from the control AMC
level of 10 Wmol/mg protein to levels as high as 50^80 Wmol/
mg protein, were observed in camptothecin-treated cells.
These results con¢rmed the above ¢ndings that caspases-1,
-3, -8 and -9 are not activated in PS-induced apoptosis in
CHO-K1 cells, in contrast to their activation in camptothe-
cin-induced apoptosis.
4. Discussion
The present results (Fig. 1) con¢rmed the PS-induced apo-
ptosis in CHO-K1 cells reported previously by Uchida et al.
[3]. In addition to methods such as the observation of chro-
matin condensation, dye exclusion and DNA ladder forma-
tion used by Uchida et al., we detected other apoptotic char-
acteristics by observing the sub-G1 fraction and PI uptake
using FCM. Furthermore, we have shown that the internal-
ization of PS is essential for induction of apoptosis by PS,
using a mutant CHO cell line, UPS-1, defective in aminophos-
pholipid translocase, responsible for PS internalization (Fig.
1A). Apoptosis induction by PS in this mutant cell line was
very low compared to that observed in wild-type CHO-K1
cells.
We found novel characteristics of the PS-induced apoptosis
based on the di¡erences in e¡ect on CHO-K1 cells between PS
and camptothecin, an inhibitor of topoisomerase 1, which is
known to induce typical apoptosis in a number of cell lines via
DNA damage [24]. In contrast to the typical loss of v8 and
cytochrome c release into the cytosol observed in camptothe-
cin-induced apoptosis, no loss of v8 and no cytochrome c
release into the cytosol occurred in PS apoptosis (Figs. 2
and 3). These ¢ndings were consistent with recent reports
showing that loss of v8 is not a universal event in the apo-
ptotic process [26,27]. It is therefore possible that PS does not
cause mitochondrial membrane permeabilization leading to
massive mitochondrial dysfunction, and consequently, PS-in-
duced apoptosis might not be mediated by mitochondria.
The marked inhibition of PS-induced apoptosis by a pan
caspase inhibitor, Z-VAD-CH2-DCB, clearly indicated the
dependency of the apoptosis on caspases (Fig. 4). 13 mamma-
lian caspases have been identi¢ed to date (caspase-1 to cas-
pase-13) [12]. An experiment using inhibitors speci¢c for each
caspase suggested that caspases-1, -3, -8, and -9 are not in-
volved in PS-induced apoptosis (Fig. 4). These results were
con¢rmed by further experiments in which the activities of
Fig. 3. Analysis of cytochrome c release from mitochondria of CHO
cells. After treatment with 1 or 3 mM PS for 24 h, cytochrome c in
the cell lysate was analyzed by Western blotting. Actin was used as
a loading control. Cyt.C: cytochrome c ; Camp: camptothecin.
Fig. 4. E¡ects of several caspase inhibitors on appearance of apo-
ptotic cells and sub-G1 fraction in CHO-K1 cells. Apoptotic cells
were scored based on chromatin condensation and nuclear segrega-
tion after Hoechst 33342 staining, and percentages of sub-G1 frac-
tions were determined as described in the text. Vertical bars repre-
sent mean þ S.E.M. (n = 3). White bars: apoptotic cells ; Shaded
bars: sub-G1 fraction.
Fig. 5. Activities of several caspases in PS- and camptothecin-
treated cells. Caspase activities in cell lysates were measured as de-
scribed in the text using £uorogenic substrates speci¢c for each cas-
pase. Vertical bars represent means þ S.E.M. (n = 3). Left to right
bars (for each treatment): caspase-3/7, caspase-1/4, caspase-8/6GB,
caspase-9.
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the enzymes were measured using substrates speci¢c for each
enzyme (Fig. 5).
The ¢nding indicating independence on initiator caspase-9
is reasonable when we consider that PS-induced apoptosis
might occur without mitochondrial membrane permeabiliza-
tion, because caspase-9 is well known to be involved in mito-
chondria-mediated apoptosis [13]. However, at present we
cannot explain the results regarding the other caspases, espe-
cially e¡ector caspases-1 and -3, in detail.
PS is an essential co-factor for PKC activation [28,29]. Our
preliminary results showed that PKC inhibitors, such as H-7
[30] and staurosporine [31], had no e¡ect on PS-induced ap-
optosis (data not shown), suggesting that PKC is not involved
in PS-induced apoptosis. Recent studies revealed that the en-
doplasmic reticulum (ER) has a role in apoptotic signaling
and execution of apoptotic cell death [32,33]. Thus, it is pos-
sible that the ER or other organelles may be involved in the
PS-induced apoptotic pathway, and as yet unknown, caspases
may mediate PS-induced apoptosis. Although many details
remain to be determined, the present results provide signi¢-
cant insight into the mechanisms that control PS-induced apo-
ptosis in CHO-K1 cells.
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